These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27556447)

  • 21. 1,2,4-Triazolo[1,5-
    Desantis J; Massari S; Corona A; Astolfi A; Sabatini S; Manfroni G; Palazzotti D; Cecchetti V; Pannecouque C; Tramontano E; Tabarrini O
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32151066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
    Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
    J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase.
    Yanagita H; Urano E; Matsumoto K; Ichikawa R; Takaesu Y; Ogata M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
    Bioorg Med Chem; 2011 Jan; 19(2):816-25. PubMed ID: 21193314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.
    Esposito F; Kharlamova T; Distinto S; Zinzula L; Cheng YC; Dutschman G; Floris G; Markt P; Corona A; Tramontano E
    FEBS J; 2011 May; 278(9):1444-57. PubMed ID: 21348941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.
    Kankanala J; Kirby KA; Liu F; Miller L; Nagy E; Wilson DJ; Parniak MA; Sarafianos SG; Wang Z
    J Med Chem; 2016 May; 59(10):5051-62. PubMed ID: 27094954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents.
    Cele FN; Ramesh M; Soliman ME
    Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Data mining and molecular dynamics analysis to detect HIV-1 reverse transcriptase RNase H activity inhibitor.
    Ghafoor NA; Kırboğa KK; Baysal Ö; Süzek BE; Silme RS
    Mol Divers; 2024 Aug; 28(4):1869-1888. PubMed ID: 37561229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding modes of two novel non-nucleoside reverse transcriptase inhibitors, YM-215389 and YM-228855, to HIV type-1 reverse transcriptase.
    Kodama E; Orita M; Masuda N; Yamomoto O; Fujii M; Ohgami T; Kageyama S; Ohta M; Hatta T; Inoue H; Suzuki H; Sudo K; Shimizu Y; Matsuoka M
    Antivir Chem Chemother; 2008; 19(3):133-41. PubMed ID: 19024630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.
    Suchaud V; Bailly F; Lion C; Tramontano E; Esposito F; Corona A; Christ F; Debyser Z; Cotelle P
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3988-92. PubMed ID: 22607675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
    ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.
    Tintori C; Corona A; Esposito F; Brai A; Grandi N; Ceresola ER; Clementi M; Canducci F; Tramontano E; Botta M
    Chembiochem; 2016 Apr; 17(8):683-8. PubMed ID: 26946324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
    Wang L; Tang J; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Xie J; Parniak MA; Sarafianos SG; Wang Z
    Eur J Med Chem; 2018 Aug; 156():652-665. PubMed ID: 30031976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
    Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG
    Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and in-vitro evaluation of novel tetrahydroquinoline carbamates as HIV-1 RT inhibitor and their antifungal activity.
    Chander S; Ashok P; Zheng YT; Wang P; Raja KS; Taneja A; Murugesan S
    Bioorg Chem; 2016 Feb; 64():66-73. PubMed ID: 26717022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.
    Fang Z; Kang D; Zhang L; Huang B; Liu H; Pannecouque C; De Clercq E; Zhan P; Liu X
    Chem Biol Drug Des; 2015 Oct; 86(4):614-8. PubMed ID: 25626467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
    Messore A; Corona A; Madia VN; Saccoliti F; Tudino V; De Leo A; Ialongo D; Scipione L; De Vita D; Amendola G; Novellino E; Cosconati S; Métifiot M; Andreola ML; Esposito F; Grandi N; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2021 Jun; 64(12):8579-8598. PubMed ID: 34106711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors.
    Massari S; Corona A; Distinto S; Desantis J; Caredda A; Sabatini S; Manfroni G; Felicetti T; Cecchetti V; Pannecouque C; Maccioni E; Tramontano E; Tabarrini O
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):55-74. PubMed ID: 30362381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
    Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.